YUNG
Corgi Longevity Consumer ETF
Corgi Longevity Consumer ETF invests in companies that focus on products and services aimed at extending human longevity and enhancing the quality of life for aging populations.
US
EQUITY
Active
MANAGEMENT STYLE
$ 1.4 M
ASSETS UNDER MGMT
35 bp
EXPENSES
Fund Basics
| Inception date | May 05, 2026 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| ELI LILLY & CO | 13.4 % |
| WELLTOWER, INC. | 5.0 % |
| BOOKING HOLDINGS INC. | 4.3 % |
| MEDTRONIC PLC | 4.1 % |
| MARRIOTT INTERNATIONAL-CL A | 4.0 % |
| ROYAL CARIBBEAN CRUISES LTD | 3.9 % |
| DELTA AIR LINES INC | 3.7 % |
| HILTON WORLDWIDE HOLDINGS, INC. | 3.7 % |
| UNITED CONTINENTAL HOLDINGS | 3.3 % |
| HUMANA INC | 3.2 % |
Constituent Breakdown
| Number of holdings | 47 |
| Herfindahl-Hirschman Index | 0 |
| Wgt avg mkt cap (mns) | $166,025 |
| Large cap (>$10bn) | 0.0% |
| Mid cap ($2-10bn) | 0.0% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 0.0% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 90.2 % |
 |
IRELAND | 4.1 % |
 |
SWITZERLAND | 2.6 % |
Historical Performance
Standardized Performance (as of 04/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -- | -- | -- | -- | -- | -- | -- | -- |
| Dividend Yield | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Returns | -- | -- | -- | -- | -- | -- | -- | -- | Ann. Volatility | -- | -- | -- | -- | -- | -- | -- | -- |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.00 | 0% |
| MSCI EAFE | 0.00 | 0% |
| MSCI Emg Mkts | 0.00 | 0% |
Liquidity Measures
| Avg. volume (000) | 3 |
| ADV traded (mns) | $0 |
| Turnover | 5.5% |
| Avg. Bid/Ask (% of price) | 0.22% |
Technical Indicators
| 30d moving avg. (EMA) | $0.00 |
| Relative strength (RSI) | 0 |
| MACD/Signal | 0.00/0.00 |
| Bollinger Bands (Upper/Lower) | $0.00/$0.00 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. YUNG |
Expenses vs. YUNG |
ALTAR Score™ vs. YUNG |
|---|---|---|---|---|
| WNDR | Corgi Travel & Leisure ETF | 32.8% | 0 bp | +2.0% |
| BEDZ | AdvisorShares Hotel ETF | 21.8% | +65 bp | +4.2% |
| AGNG | Global X Aging Population ETF | 18.7% | +15 bp | +1.2% |
| VHT | Vanguard Health Care ETF | 16.8% | -26 bp | +2.0% |
| IYH | iShares U.S. Healthcare ETF | 16.6% | +5 bp | +2.7% |
| XLV | Health Care Select Sector SPDR | 16.2% | -27 bp | +3.5% |
| FHLC | Fidelity MSCI Health Care Index ETF | 15.7% | -27 bp | +2.2% |
| OZEM | Roundhill GLP-1 & Weight Loss ETF | 14.5% | +24 bp | +2.5% |
| THNR | Amplify Weight Loss Drug & Treatment ETF | 14.5% | +24 bp | +2.9% |
| CPAI | Counterpoint Quantitative Equity ETF | 14.3% | +40 bp | +1.6% |
Risk and Returns: YUNG vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 6/2/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
3.7%
ALTAR SCORE™
23rd
PERCENTILE
UNDERWEIGHT
ETFRC RATING
There are 1,400 funds in the US Equity category with an average
ALTAR Score™ of 5.3% and a standard deviation
of 2.1%. YUNG's ALTAR Score™ is approximately -0.7 standard
deviations above the category average. This places YUNG in the 23rd percentile
among funds in the category.
Sell-Side Consensus
$30.51
PRICE TARGET
+16.7%
UPSIDE